Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.

Tural, DenizOlmez, Omer FatihSumbul, Ahmet TanerArtac, MehmetOzhan, NailAkar, EmreCakar, Burcu2024-06-122024-06-1220210732-183X1527-7755https://doi.org/10.1200/JCO.2021.39.6_suppl.409https://hdl.handle.net/20.500.14551/25945ASCO Genitourinary Cancers Symposium (GU ASCO) -- FEB 11-13, 2021 -- ELECTR NETWORK[Abstract Not Available]en10.1200/JCO.2021.39.6_suppl.409info:eu-repo/semantics/closedAccess[No Keywords]Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.Conference Object396Q1WOS:000636801500412